IE57967B1 - An antibiotic compound,a method for its preparation and compositions containing it - Google Patents

An antibiotic compound,a method for its preparation and compositions containing it

Info

Publication number
IE57967B1
IE57967B1 IE22/85A IE2285A IE57967B1 IE 57967 B1 IE57967 B1 IE 57967B1 IE 22/85 A IE22/85 A IE 22/85A IE 2285 A IE2285 A IE 2285A IE 57967 B1 IE57967 B1 IE 57967B1
Authority
IE
Ireland
Prior art keywords
stearate
erythromycin
acetyl
solvent
salt
Prior art date
Application number
IE22/85A
Other languages
English (en)
Other versions
IE850022L (en
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of IE850022L publication Critical patent/IE850022L/en
Publication of IE57967B1 publication Critical patent/IE57967B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
IE22/85A 1984-01-06 1985-01-04 An antibiotic compound,a method for its preparation and compositions containing it IE57967B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (2)

Publication Number Publication Date
IE850022L IE850022L (en) 1985-07-06
IE57967B1 true IE57967B1 (en) 1993-06-02

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
IE22/85A IE57967B1 (en) 1984-01-06 1985-01-04 An antibiotic compound,a method for its preparation and compositions containing it

Country Status (38)

Country Link
US (1) US4599326A (enExample)
JP (1) JPS60158197A (enExample)
KR (1) KR900006237B1 (enExample)
AT (1) AT386414B (enExample)
AU (1) AU565688B2 (enExample)
BE (1) BE901411A (enExample)
BG (1) BG43189A3 (enExample)
CA (1) CA1224461A (enExample)
CH (1) CH666275A5 (enExample)
CS (1) CS247191B2 (enExample)
CY (1) CY1462A (enExample)
DE (1) DE3500179A1 (enExample)
DK (1) DK149776C (enExample)
ES (1) ES8605818A1 (enExample)
FI (1) FI77249C (enExample)
FR (1) FR2557878B1 (enExample)
GB (1) GB2152502B (enExample)
HK (1) HK11590A (enExample)
HU (1) HU196221B (enExample)
IE (1) IE57967B1 (enExample)
IL (1) IL73885A (enExample)
IS (1) IS2968A7 (enExample)
IT (1) IT1184304B (enExample)
KE (1) KE3841A (enExample)
LU (1) LU85721A1 (enExample)
MA (1) MA20316A1 (enExample)
MX (1) MX156277A (enExample)
NL (1) NL8403979A (enExample)
NO (1) NO160263C (enExample)
NZ (1) NZ210606A (enExample)
PH (1) PH22471A (enExample)
PL (1) PL144349B1 (enExample)
PT (1) PT79777B (enExample)
RO (1) RO91262B (enExample)
SE (1) SE461854B (enExample)
SU (1) SU1410866A3 (enExample)
YU (1) YU44485B (enExample)
ZA (1) ZA8410143B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
WO2004004693A1 (en) * 2002-07-05 2004-01-15 Collgegium Pharmaceutical Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP2007509975A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン ギャバペンチン及びプレギャバリンの増加された吸収のための組成物及び投与形態物
LT1765292T (lt) 2004-06-12 2018-01-10 Collegium Pharmaceutical, Inc. Nuo piktnaudžiavimo apsaugotos vaistų formos
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
EP2505189B1 (en) 2006-06-23 2018-08-08 Aegis Therapeutics, LLC Stabilizing alkylglycoside compositions and method thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CN103796666B (zh) 2011-05-18 2018-07-06 欧莫德里斯制药公司 改良的肽药物
EP3444281B1 (en) 2012-11-20 2021-11-03 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
AU2013347975B2 (en) 2012-11-20 2018-07-26 Mederis Diabetes, Llc Improved peptide pharmaceuticals for insulin resistance
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
FI3155017T3 (fi) 2014-05-28 2024-04-17 Mederis Diabetes Llc Parannettuja peptidilääkkeitä insuliiniresistenssiin
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
KR20200010343A (ko) 2017-05-19 2020-01-30 루넬라 바이오테크 인코포레이티드 안티미토신: 암 줄기 세포를 근절하기 위한 미토콘드리아 생물발생의 표적화 억제제
WO2019108729A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス，エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法
AU2019217643B2 (en) 2018-02-06 2021-10-28 ARS Pharmaceuticals Operations, Inc. Intranasal epinephrine formulations and methods for the treatment of disease
MX2021007345A (es) * 2018-12-17 2021-07-15 Lunella Biotech Inc Terapias de combinacion triple para fijar como objetivo mitocondrias y aniquilar celulas madre cancerosas.
BR112021011964A2 (pt) * 2018-12-17 2021-09-08 Lunella Biotech, Inc. Terapias de combinação tripla para antienvelhecimento

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DK149776B (da) 1986-09-29
YU44485B (en) 1990-08-31
GB2152502B (en) 1987-10-07
IT8519012A0 (it) 1985-01-04
IL73885A0 (en) 1985-03-31
HK11590A (en) 1990-02-23
ZA8410143B (en) 1985-08-28
KR850005452A (ko) 1985-08-26
HU196221B (en) 1988-10-28
MX156277A (es) 1988-08-04
ATA985A (de) 1988-01-15
KE3841A (en) 1989-04-07
GB8432368D0 (en) 1985-02-06
NZ210606A (en) 1987-08-31
IT1184304B (it) 1987-10-28
AU3705984A (en) 1985-07-11
CH666275A5 (de) 1988-07-15
GB2152502A (en) 1985-08-07
ES8605818A1 (es) 1986-04-01
NO160263B (no) 1988-12-19
SU1410866A3 (ru) 1988-07-15
PT79777B (en) 1986-10-21
FR2557878A1 (fr) 1985-07-12
IS2968A7 (is) 1985-04-03
FI77249C (fi) 1989-02-10
FI850023L (fi) 1985-07-07
MA20316A1 (fr) 1985-10-01
LU85721A1 (fr) 1985-07-24
DE3500179A1 (de) 1985-07-18
BG43189A3 (en) 1988-04-15
JPH029040B2 (enExample) 1990-02-28
RO91262B (ro) 1987-07-01
US4599326A (en) 1986-07-08
CS247191B2 (en) 1986-12-18
JPS60158197A (ja) 1985-08-19
FI850023A0 (fi) 1985-01-03
DE3500179C2 (enExample) 1989-08-24
ES539349A0 (es) 1986-04-01
HUT37628A (en) 1986-01-23
PL144349B1 (en) 1988-05-31
KR900006237B1 (ko) 1990-08-27
SE8406671L (sv) 1985-07-07
DK149776C (da) 1987-04-21
IL73885A (en) 1988-10-31
AU565688B2 (en) 1987-09-24
DK5884D0 (da) 1984-01-06
NO160263C (no) 1989-03-29
AT386414B (de) 1988-08-25
CA1224461A (en) 1987-07-21
IE850022L (en) 1985-07-06
SE461854B (sv) 1990-04-02
NL8403979A (nl) 1985-08-01
PT79777A (en) 1985-01-01
FR2557878B1 (fr) 1988-01-15
PH22471A (en) 1988-09-12
YU2085A (en) 1987-12-31
PL251457A1 (en) 1985-11-05
CY1462A (en) 1989-07-21
RO91262A (ro) 1987-06-30
BE901411A (fr) 1985-04-16
SE8406671D0 (sv) 1984-12-28
FI77249B (fi) 1988-10-31
NO850007L (no) 1985-07-08
DK5884A (da) 1985-07-07

Similar Documents

Publication Publication Date Title
US4599326A (en) Acetyl erythromycin stearate, and compositions containing it
JP3560653B2 (ja) イツリンａの製造法及び抗深在性真菌症剤
US4722927A (en) Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase
SU818492A3 (ru) Способ получени деоксинаразино-ВОгО АНТибиОТичЕСКОгО КОМплЕКСА
JPH0645543B2 (ja) 魚病の予防，治療剤
CA1140857A (en) Spiroketalins and their applications
JP3315826B2 (ja) ビフィズス菌増殖促進組成物
EP0369503B1 (en) Method for the control of pneumocystis carinii
JPS6234038B2 (enExample)
CS248021B2 (en) Agent for encreasing the utilization of fodder with ruminants
US3962455A (en) Antibiotic ascofuranone and process for the production thereof
HU193905B (en) Process for preparing glycopeptide antibiotics by means of bioconversion
NO813411L (no) Nye prostaglandiner
JPH07289273A (ja) ナフトキノン誘導体
JP2780828B2 (ja) ポリエーテル抗生物質ｍｉ２１５―ｎｆ３物質及びその製造法、並びに鶏のコクシジウム症の防除剤
JPS5948812B2 (ja) 動物用成長促進剤
JPS5849386A (ja) セフアロスポリン誘導体及び該誘導体を含有する医薬
US3350267A (en) Controlling antibiotic resistant strains of micrococcus pyogenes and other pathogenic bacteria with novobiocin and other antibiotics
JPS5950318B2 (ja) 新規抗生物質ｓｙ−２物質
JPS6332794B2 (enExample)
JPS59128388A (ja) セフアロスポリン誘導体及び該誘導体を含有する薬剤
JP2002193903A (ja) ビフィズス菌増殖促進組成物
PL88752B1 (enExample)
DD231796A5 (de) Antibiotische verbindungen, herstellungsverfahren und zusammensetzungen, die diese stoffe enthalten
PT92525A (pt) Processo para a preparacao de um complexo de compostos glicopeptidicos

Legal Events

Date Code Title Description
MM4A Patent lapsed